Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version].
Schütte W, Gütz S, Nehls W, Blum TG, Brückl W, Buttmann-Schweiger N, Büttner R, Christopoulos P, Delis S, Deppermann KM, Dickgreber N, Eberhardt W, Eggeling S, Fleckenstein J, Flentje M, Frost N, Griesinger F, Grohé C, Gröschel A, Guckenberger M, Hecker E, Hoffmann H, Huber RM, Junker K, Kauczor HU, Kollmeier J, Kraywinkel K, Krüger M, Kugler C, Möller M, Nestle U, Passlick B, Pfannschmidt J, Reck M, Reinmuth N, Rübe C, Scheubel R, Schumann C, Sebastian M, Serke M, Stoelben E, Stuschke M, Thomas M, Tufman A, Vordermark D, Waller C, Wolf J, Wolf M, Wormanns D. Schütte W, et al. Among authors: tufman a. Pneumologie. 2023 Oct;77(10):671-813. doi: 10.1055/a-2029-0134. Epub 2023 Oct 26. Pneumologie. 2023. PMID: 37884003 Free article. German.
Corrigendum to "Indirect comparison of capmatinib treatment from GEOMETRY mono-1 trial to SOC in German patients with locally advanced or metastatic NSCLC harboring METex14 skipping mutations" [Eur J Cancer 207 (2024) 114158].
Kron A, Scheffler M, Wiesweg M, Hummel HD, Kulhavy J, Gatteloehner S, Kollmeier J, Schubart C, Groß T, Demes MC, Keymel S, Joosten M, Merkelbach-Bruse S, Woelwer CB, Tufman A, Kauffmann-Guerrero D, Oeser K, Zehaczek M, Jeratsch U, Wolf J. Kron A, et al. Among authors: tufman a. Eur J Cancer. 2024 Dec;213:115074. doi: 10.1016/j.ejca.2024.115074. Epub 2024 Oct 30. Eur J Cancer. 2024. PMID: 39476444 Free article. No abstract available.
Software-assisted structured reporting and semi-automated TNM classification for NSCLC staging in a multicenter proof of concept study.
Heimer MM, Dikhtyar Y, Hoppe BF, Herr FL, Stüber AT, Burkard T, Zöller E, Fabritius MP, Unterrainer L, Adams L, Thurner A, Kaufmann D, Trzaska T, Kopp M, Hamer O, Maurer K, Ristow I, May MS, Tufman A, Spiro J, Brendel M, Ingrisch M, Ricke J, Cyran CC. Heimer MM, et al. Among authors: tufman a. Insights Imaging. 2024 Oct 28;15(1):258. doi: 10.1186/s13244-024-01836-z. Insights Imaging. 2024. PMID: 39466506 Free PMC article.
Prognostic significance of pretreatment PET parameters in inoperable, node-positive NSCLC patients with poor prognostic factors undergoing hypofractionated radiotherapy: a single-institution retrospective study.
Zinn AB, Kenndoff S, Holzgreve A, Käsmann L, Guggenberger JE, Hering S, Mansoorian S, Schmidt-Hegemann NS, Reinmuth N, Tufman A, Dinkel J, Manapov F, Belka C, Eze C. Zinn AB, et al. Among authors: tufman a. EJNMMI Rep. 2024 Oct 8;8(1):32. doi: 10.1186/s41824-024-00220-w. EJNMMI Rep. 2024. PMID: 39375264 Free PMC article.
Tumor board simulation improves interdisciplinary decision-making in medical students.
Fink K, Forster M, Oettle M, Büttner M, Eze C, Käsmann L, Tufman A, Kauffmann-Guerrero D, Bolt TA, Kovacs J, Neumann J, Mücke J, Heuser S, Corradini S, Walter F, Niyazi M, Belka C, Dreyling M, Fischer MR, Fleischmann DF. Fink K, et al. Among authors: tufman a. J Cancer Res Clin Oncol. 2024 Aug 30;150(8):407. doi: 10.1007/s00432-024-05908-x. J Cancer Res Clin Oncol. 2024. PMID: 39212783 Free PMC article.
126 results